SOCS2

suppressor of cytokine signaling 2

8835

O14508

chr12: 93,569,814-93,583,487

SOCS3

suppressor of cytokine signaling 3

9021

O14543

chr17: 78,356,778-78,360,077

MSTN

myostatin

2660

O14793

chr2: 190,055,697-190,062,729

SOCS1

suppressor of cytokine signaling 1

8651

O15524

chr16: 11,254,405-11,256,179

IL1B

interleukin 1 beta

3553

P01584

chr2: 112,829,751-112,836,903

AHSG

alpha-2-HS-glycoprotein

197

P02765

chr3: 186,612,923-186,621,318

PRKCB

protein kinase C, beta

5579

P05771

chr16: 23,836,001-24,220,611

PTPN2

protein tyrosine phosphatase, non-receptor type 2

5771

P17706

chr18: 12,785,478-12,929,643

ENPP1

ectonucleotide pyrophosphatase/phosphodiesterase 1

5167

P22413

chr6: 131,808,016-131,895,155

IRS1

insulin receptor substrate 1

3667

P35568

chr2: 226,731,317-226,799,759

TSC2

tuberous sclerosis 2

7249

P49815

chr16: 2,047,465-2,088,720

RELA

v-rel avian reticuloendotheliosis viral oncogene homolog A

5970

Q04206

chr11: 65,653,596-65,663,094

PRKCQ

protein kinase C, theta

5588

Q04759

chr10: 6,427,143-6,580,301

PRKCD

protein kinase C, delta

5580

Q05655

chr3: 53,156,009-53,192,717

GRB10

growth factor receptor bound protein 10

2887

Q13322

chr7: 50,590,063-50,793,462

KANK1

KN motif and ankyrin repeat domains 1

23189

Q14678

chr9: 470,291-746,106

PID1

phosphotyrosine interaction domain containing 1

55022

Q7Z2X4

chr2: 228,850,526-229,271,285

INPP5K

inositol polyphosphate-5-phosphatase K

51763

Q9BT40

chr17: 1,494,571-1,516,888

LMBRD1

LMBR1 domain containing 1

55788

Q9NUN5

chr6: 69,675,802-69,797,111